LLY
Eli Lilly and CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #352
- Final score
- 55.90
- Years on list
- 6
↘ Down 57 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- LLY· Eli Lilly and Company
- BMY· Bristol-Myers Squibb Company
- RVTY· Revvity, Inc.
Figure 01 · Side-by-side summary
The headline numbers
BMY
Bristol-Myers Squibb CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #318
- Final score
- 57.23
- Years on list
- 6
↘ Down 237 since 2020
RVTY
Revvity, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #364
- Final score
- 55.42
- Years on list
- 3
↗ Climbed 25 since 2023
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | LLY | BMY | RVTY |
|---|---|---|---|
| Climate Change | 62.9 | 73.2 | 56.7 |
| Employee Relations | 55.1 | 39.9 | 59.0 |
| Environment | 64.7 | 45.6 | 55.4 |
| Stakeholders & Society | 51.4 | 73.4 | 54.7 |
| Human Rights | 38.0 | 58.0 | 51.0 |
| Governance | 45.4 | 50.5 | 50.9 |
| Performance Rating | 67.0 | 68.4 | 55.0 |